German Trade Distributors Stock News

ADM Hamburg (DB:OEL) has kicked off FY 2025 with first half revenue of €207.5 million and EPS of €6.48, set against trailing twelve month earnings growth of 260.1% and a net profit margin of 0.3% versus 0.06% a year earlier. The company has seen revenue move from €247.7 million in the first half of 2024 to €182.4 million in the second half of 2024 and then to €207.5 million in the first half of 2025. EPS shifted from €1.31 to a loss of €0.97 and then to €6.48 over the same periods. With multi...

LEG Immobilien (XTRA:LEG) has completed its scrip dividend for the 2025 financial year, with about €63.1 million reinvested and roughly 1.28 million new shares issued, modestly expanding the company’s equity base. See our latest analysis for LEG Immobilien. LEG Immobilien’s latest scrip dividend comes as the stock trades at €55.2, with a 1 day share price return of 2.32% and a year to date share price return down 10.10%, while the 3 year total shareholder return is positive at 22.97% despite...

Without a specific news event as a catalyst, Allianz (XTRA:ALV) draws attention today mainly through its current share price of €407.10 and its recent total return profile for investors. See our latest analysis for Allianz. The recent 4.68% 30 day share price return and 16.02% 90 day share price return suggest momentum has been building in Allianz. At the same time, the 25.12% 1 year total shareholder return and 144.97% 5 year total shareholder return point to a strong longer term profile. If...

A new market research report on stem cell culture media has put Sartorius (XTRA:SRT3) in focus, highlighting the company as a key participant as pharmaceutical and biotechnology groups expand their use of stem cell technologies. See our latest analysis for Sartorius. Sartorius shares, which last closed at €219.4, have had a mixed run, with the 1-year total shareholder return of 2.88% contrasting with weaker multi year figures. This suggests recent momentum is stabilising after earlier...

Europe’s new biometric border controls are turning into a stress test for travel infrastructure, with reports of hours long queues and potential flight disruption at major hubs. For investors, the question is how this kind of operational strain might ripple through stocks that depend on smooth airport throughput and passenger flows. This article looks at three European Travel Disruption stocks that appear more exposed to the EES turmoil, and why the current situation could weigh on their...

The euro’s sharp slide, weaker Eurozone data, and softer rate hike expectations are reshaping the risk profile for some of the region’s most policy sensitive stocks. Lower energy costs and a stronger US dollar are not a simple win or loss for investors, as they can pressure margins, earnings quality, and valuations in different ways. This article focuses on the downside by spotlighting 3 Eurozone Sensitive Stocks Impacted by Weak Currency and Rate Outlook that screen as particularly exposed...

Carl Zeiss Meditec (XTRA:AFX) is back in focus after ZEISS Medical Technology disclosed two recent partnership agreements, one centered on virtual reality glaucoma testing and another on deploying VISUMAX 800 lasers across Aier Eye Hospital’s network. See our latest analysis for Carl Zeiss Meditec. The recent virtual reality glaucoma collaboration and VISUMAX 800 rollout news arrives as Carl Zeiss Meditec shares trade at €27.76, with short term momentum reflected in a 7 day share price return...

It looks like InnoTec TSS AG ( FRA:TSS ) is about to go ex-dividend in the next three days. Typically, the ex-dividend...

Readers hoping to buy Nagarro SE ( ETR:NA9 ) for its dividend will need to make their move shortly, as the stock is...

GEA Group (XTRA:G1A) has drawn fresh investor attention after presenting its 2030 strategy, which outlines goals for revenue above €7b, higher EBITDA margins, expanded service and digital sales, and sizeable cost savings. See our latest analysis for GEA Group. GEA Group's new 2030 plan lands after a mixed year for the stock, with a 7.21% 1 month share price return but a 2.06% decline over 3 months, set against a 66.49% 3 year total shareholder return that points to longer term momentum. If...

Readers hoping to buy Dermapharm Holding SE ( ETR:DMP ) for its dividend will need to make their move shortly, as the...

PUMA (XTRA:PUM) is back in focus after fresh product and branding activity, including the PUMA NITRO Lab launch in Los Angeles and strong athlete showings at the 2026 HYROX World Championships. See our latest analysis for PUMA. PUMA's recent marketing and product launches come as the stock trades at €26.66, with a 23.65% 90 day share price return suggesting momentum has picked up again despite a weaker 30 day share price return and a mixed multi year total shareholder return profile. If this...

adidas (XTRA:ADS) stock is in focus after two fresh product moves, as the company pushes into professional workwear with the ADIDAS PRO WORK safety footwear range and taps gaming fans through its collaboration with Brawl Stars. See our latest analysis for adidas. Those product launches land at a time when momentum in adidas stock has been firming up, with a 30 day share price return of 11.50% and a 90 day share price return of 31.25%. This comes even as the 1 year total shareholder return is...

Bayer (XTRA:BAYN) is back in focus after U.S. regulators approved its new MRI contrast agent AMBELVIST, and the company moved forward on multiple fronts in research partnerships and oncology development. See our latest analysis for Bayer. Recent gains around the AMBELVIST approval and AI drug discovery partnership come on top of a 4.96% 7 day share price return and a 50.41% total shareholder return over the past year, while longer term total shareholder returns over three and five years...

Merck KGaA (XTRA:MRK) has agreed to fund and potentially acquire Saturnus Bio, a Versant Ventures founded biotech, in a research stage collaboration focused on rare genetic cardiomyopathies, a field currently lacking approved targeted therapies. See our latest analysis for Merck KGaA. Against this backdrop of new cardiology ambitions, Merck KGaA’s share price has gained momentum, with a 31.06% 3 month share price return and a 29.51% 1 year total shareholder return, while 3 and 5 year total...

Germany’s decision to scrap the multibillion euro F126 frigate programme and pivot toward eight Meko ships has not only shaken defence headlines, it has also shifted attention across large German industrial conglomerates. With Rheinmetall shares falling 12% after losing the expected €12.8b lead role and around €2b slated for write offs, investors are reassessing where the real opportunities and risks sit. This article looks at three stocks from the German Industrial Conglomerates screener...

BAUER Aktiengesellschaft's ( HMSE:B5A0 ) healthy profit numbers didn't contain any surprises for investors. However the...

In June 2026, Redcare Pharmacy NV raised its full-year 2026 revenue growth guidance from 13%–15% to 15%–17%, while also moving from the Germany MDAX Index to the SDAX Index. This combination of upgraded outlook and index reclassification highlights how the market is reassessing Redcare Pharmacy’s scale and growth profile within Germany’s equity landscape. We’ll now examine how Redcare Pharmacy’s upgraded 2026 revenue guidance shapes the company’s investment narrative in light of recent...

HORNBACH Holding AG & Co. KGaA ( ETR:HBH ) came out with its first-quarter results last week, and we wanted to see how...

Mercedes-Benz Group plans to negotiate fresh cost-cutting measures across the business. The company is targeting 70% AI adoption across its operations by the end of the year. These steps are intended to reshape how Mercedes-Benz Group runs its manufacturing and corporate functions. Mercedes-Benz Group (XTRA:MBG) is moving to tighten costs and expand the use of AI at a time when its stock has come under pressure. The share price stands at €45.715, with the stock down 7.4% over the past week,...

In June 2026, China’s Supreme People’s Court upheld a final sales injunction against Infineon Technologies’ Gallium Nitride (GaN) products in mainland China, confirming earlier findings that they infringed two of Innoscience’s GaN invention patents and ordering an immediate halt to related sales, offers for sale, and imports, plus RMB 10 million (about US$1.38 million) in damages. This ruling removes Infineon’s contested GaN portfolio from one of the world’s largest semiconductor markets at...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Nabaltec AG...

European markets have shown a modest uptick, with the STOXX Europe 600 Index rising by 0.62% over the past week, buoyed by positive geopolitical developments between the U.S. and Iran. In this context of mixed macroeconomic data, investors are increasingly looking at smaller companies for potential opportunities. Although 'penny stocks' is an older term, it still applies to small or emerging firms that may offer value when they possess strong financials and growth potential.

Schulte-Schlagbaum AG ( DUSE:SSS ) is about to trade ex-dividend in the next day or so. The ex-dividend date is usually...